Results 71 to 80 of about 3,606,854 (303)

Valuation in the Pharmaceutical Industry [PDF]

open access: yesSSRN Electronic Journal, 2010
Valuation models are used extensively in Finance and Accounting to investigate various empirical questions. Conventional valuation models express firm value as a function of discounted dividends, discounted abnormal earnings, discounted cash flows, or price multiples.
openaire   +1 more source

Electrochemical Pathways for Nitrate Conversion to Ammonia: From Environmental Challenges to Ammonia Economy

open access: yesAdvanced Functional Materials, EarlyView.
This perspective presents recent advances in electrocatalytic nitrate reduction, focusing on reaction mechanisms, catalyst design, and electrolyzer configurations. Key challenges in selectivity, stability, and practical wastewater treatment are highlighted, while future directions for advancing sustainable ammonia synthesis and nitrate remediation are ...
Xintong Li   +9 more
wiley   +1 more source

The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry [PDF]

open access: yes
While most economists believe that public scientific research fuels industry innovation and economic growth, systematic evidence supporting this relationship is surprisingly limited. In a recent study, Acemoglu and Linn (2004) identified market size as a
Toole, Andrew A.
core  

IMPLEMENTATION MECHANISMS OF INNOVATIVE STRATEGIES IN PHARMACEUTICAL INDUSTRY AND KEY INVESTMENT PROJECTS

open access: yesСтатистика и экономика, 2016
In this article, the author reflects the strategic goals, principles and objectives of the pharmaceutical industry, the situation in the industry, the industry's problems, methods and ways of solving these problems.
Marko Jovanovich
doaj   +1 more source

An Integrated Oxygen‐Supplying Device and Predictive Multiphysics Model for Extended Ambient Transport of Insulin‐Producing Cells

open access: yesAdvanced Functional Materials, EarlyView.
Cell therapies typically rely on cold‐chain logistics and cryopreservation, limiting access and compromising cell quality. Here, a dual‐chamber device separates an oxygen‐supplying chamber from a hyaluronic acid cargo chamber, sustaining oxygen delivery for over 70 h and enabling ambient‐temperature shipment.
Daniel A. Domingo‐Lopez   +9 more
wiley   +1 more source

La industria farmacéutica granadina durante el franquismo (19361975)

open access: yesArs Pharmaceutica
Resumen Objetivo: Estudiamos los laboratorios farmacêuticos que estuvieron en funcionamiento en la provincia de Granada durante el franquismo (1936-1975), tanto los creados con anterioridad a la guerra civil, como los establecidos durante este conflicto
Antonio Bueno González   +1 more
doaj   +1 more source

Excess in the pharmaceutical industry [PDF]

open access: yesCanadian Medical Association Journal, 2004
The main point about excess in the pharmaceutical industry is how much there is of it. Here I can touch on only a few specifics about this altogether over-the-top business. ![Figure][1] Figure. Photo by: Earthlore Although the pharmaceutical industry claims to be a high-risk business,
openaire   +2 more sources

Myogenic Fusogen‐Engineered Lipid Nanoparticles Enhance mRNA Delivery in Skeletal Muscle

open access: yesAdvanced Functional Materials, EarlyView.
This study reports a biomimetic strategy of engineering full‐length Myomaker, a muscle‐specific fusogen, into lipid nanoparticles (LNPs) to harness the native myoblast fusion capability for skeletal muscle mRNA delivery. The resulting Mymk‐LNPs enhance transfection in differentiating myocytes and enable Cre‐mediated reporter activation in injured ...
Fangyu Zhang   +18 more
wiley   +1 more source

Servitization in the pharmaceutical industry

open access: yes, 2015
Servitization in pharmaceutical ...
Morales, J., Ruiz-Alba, J., Soares, A.
core  

Transparency and the pharmaceutical industry [PDF]

open access: yesJournal of the Royal College of Physicians of Edinburgh, 2014
Carefully conducted and appropriately reported clinical trials are of fundamental importance in evidence-based medicine. This applies to both new and established treatments (see, for example, p291–2 of this issue). It is estimated that about half of all clinical trials are not reported; this is a problem of which we have been aware since 1986, if not ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy